Modified coronavirus structural protein
US-2024226271-A1 · Jul 11, 2024 · US
Production of hemagglutinin-neuraminidase protein in microalgae
US9012197B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9012197-B2 |
| Application number | US-98032010-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 28, 2010 |
| Priority date | Dec 28, 2009 |
| Publication date | Apr 21, 2015 |
| Grant date | Apr 21, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention is directed to recombinant microalgal cells and their use in production of heterologous hemagglutinin-neuraminidase (HN) polypeptides, as well as compositions and uses thereof.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for production of a hemagglutinin-neuraminidase (HN) polypeptide, wherein said HN polypeptide is glycosylated and comprises full length HN polypeptide, a membrane domain and a native HN signal peptide, said method comprising culturing a recombinant microalgal host cell in a medium, wherein the recombinant microalgal host cell comprises a heterologous nucleic acid molecule comprising the sequence of SEQ ID NO:1 encoding the HN polypeptide to produce…
Assignees
Inventors
Classifications
- C12N15/8257Primary
Chemistry & Metallurgy · mapped topic
- C12Y302/01018Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9012197B2 cover?
- The present invention is directed to recombinant microalgal cells and their use in production of heterologous hemagglutinin-neuraminidase (HN) polypeptides, as well as compositions and uses thereof.
- Who is the assignee on this patent?
- Bayne Anne-Cécile V, Lippmeier James Casey, Apt Kirk Emil, and 4 more
- What technology area does this patent fall under?
- Primary CPC classification C12N15/8257. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).